Israeli company plans to make insulin injections obsolete

Kadimastem aims to render needles a thing of the past for diabetes patients by developing a stem-cell mechanism that creates insulin in the body.

Naama Barak is a writer at ISRAEL21c. A PhD student at the Hebrew University of Jerusalem, she loves all things history and politics. Food and fashion come a close second. Prior to joining ISRAEL21c, Naama worked for Israel's leading English-language dailies and cutting-edge startups.